Multibagger in just one year: Board announced bonus issue of equity shares!

Praveenkumar Yadav
/ Categories: Trending, Mindshare
Multibagger in just one year: Board announced bonus issue of equity shares!

Shares of this company have gained more than 70 per cent in the last six months.

Indo US Bio-Tech Limited informed in the exchange filing that the company’s board has approved the bonus issue of equity shares in a ratio of 1:1, one equity share for every one equity share held on the record date. The board of the company has also approved an increase in the authorized share capital of the company from Rs. 11,00,00,000 (Eleven Crores only), divided into 1,10,00,000 Equity Shares of Re. 10/- (Rupee Ten Only) each to Rs. 21.00,00,000 (Twenty-one Crores only), divided into 2,10,00,000 Equity Shares of Re. 10/- (Rupee Ten Only) each and the consequent change in the capital clause of the memorandum of association of the company.

The company posted fantastic half-yearly Results. In H1FY23, the revenue of the company stood at Rs 33.61 crore which grew by 36.93 per cent YoY. The operating profit of the company stood at Rs 5.17 crore, which grew by 41.06 per cent YoY, while the PAT of the company grew by 55.61 per cent YoY, staying at Rs 4.14 crore.

Indo Us Bio-Tech Limited is involved in the production of various types of agricultural crop seeds like vegetable seeds, pulses, cereals, oilseed marketings, and spice seeds.

Furthermore, Indo Us Bio-Tech Limited has delivered multibagger returns to its shareholders. During this period, shares of Indo Us Bio-Tech Limited surged from Rs 82.50 on July 08, 2022, to Rs 388.00 on July 07, 2023, an increase of about 370 per cent in a one-year holding period. And investors should keep a close eye on this stock.

DSIJ offers a service 'Micro Marvel' with recommendations for micro-cap stocks based on research and analysis to help subscribers make informed investment decisions. If this interests you, then do download the service details pdf here

Rate this article:
4.0

1 comments on article "Multibagger in just one year: Board announced bonus issue of equity shares!"

Avatar image

Paisawala

Was Indo US bio tech on your recommendation list last year? Your recommendations are good which still has to be verified by buyer before investing. It's true that no body can predict the future of a company. At least I get to know about new companies and business from your fortnightly magazine

Leave a comment

Add comment

DSIJ MINDSHARE

Mkt Commentary18-Jul, 2024

Penny Stocks18-Jul, 2024

Multibaggers18-Jul, 2024

Penny Stocks18-Jul, 2024

Multibaggers18-Jul, 2024

Knowledge

General9-Jul, 2024

General9-Jul, 2024

General9-Jul, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR